Going beyond HRR mutations: A deep-learning approach on HRD detection in ovarian cancer...
Going beyond HRR mutations: A deep-learning approach on HRD detection in ovarian cancer
read more
Events
Accelerating access to precision oncology with decentralized MSK solutions
SOPHiA GENETICS is collaborating with Memorial Sloan Kettering Cancer Center (MSK) to decentralize...
Optimized variant prioritization for enhanced insights: SOPHiA DDM™ and Alamut™ Visual Plus in action
Optimized variant prioritization for enhanced insights: SOPHiA DDM™️ and Alamut™️ Visual Plus in...
The critical role of transcript analysis for refining the classification of variants associated with constitutional disorders
The critical role of transcript analysis for refining the classification of variants associated...
AMP 2023
SOPHiA GENETICS™ is excited to be a part of the Association of Molecular Pathology annual meeting,...
SITC 2023
SOPHiA GENETICS is excited to join the Society of Immunotherapy of Cancer annual meeting in person...
AI-Driven Precision Oncology Summit
Join us for an exclusive event at the NASDAQ Headquarters to shape the future of AI in precision oncology
European Congress of Pathology
SOPHiA GENETICS™ is excited to join the European Congress of Pathology annual meeting, held in...
SFMPP 2023
SOPHiA GENETICS™ is excited to participate in the "9ème congrès de la SFMPP" taking place...
ASHG 2023
SOPHiA GENETICS™ is excited to be a part of the American Society of Human...
SOPHiA DDM™ Community CLL Clonality Solution: The importance of biomarker analysis in Chronic Lymphoblastic Leukemia
Lymphoid neoplasms encompassing lymphomas and some leukemia like Chronic Lymphocytic Leukaemia...
AMP Europe
SOPHiA GENETICS™ is excited to be a part of the Association for Molecular Pathology (AMP) 2023...